By binding to both vaccine antibodies and a protein frequently upregulated in tumors, a molecular bridge harnesses antiviral immunity to fight cancer.

Programmed cell death (PCD) stands at the forefront of innovation in experimental pharmacology and drug discovery, providing fundamental insights into ...

A common pneumonia bacterium has been found hiding inside the human eye, and scientists say it may quietly accelerate Alzheimer’s disease.

From molecular chaperones to mitochondrial failure, discover how heat reshapes the human transcriptome and drives the biological cascade that links rising temperatures to organ injury and public ...

Molecular Basis of Disease finds that cannabidiol (CBD) can selectively impair the growth of HER2-positive breast cancer cells by lowering HER2 protein levels and activating specific, non-apoptotic ...

Gov. Ron DeSantis signed the death warrant for Michael King, convicted in the 2008 murder of Denise Amber Lee.

Researchers have resolved a 50-year-old scientific mystery by identifying the molecular mechanism that allows tissues to ...

Brain tumors do not just invade healthy tissue. They also physically squeeze it, and that mechanical compression may be enough to trigger neuron death in the surrounding brain. Two peer-reviewed ...

New research shows that physical pressure from brain tumors or injuries triggers a "self-destruction" program in neurons, leading to irreversible brain damage.

Because many different types of cancer cells overexpress programmed death-ligand 1 (PD-L1), this cell surface protein is a major target of cancer immunotherapy. Unfortunately, drugs that target it do ...

Phase 3 trial data show datopotamab deruxtecan reduces the risk of disease progression or death in patients with metastatic TNBC.

A small study suggests Mavenclad’s effectiveness in MS may be linked to how regulatory T-cells respond to treatment.